Search Results - "Holm, Manne"

Refine Results
  1. 1

    Impact of morphine dose on ticagrelor uptake and platelet inhibition in patients with ST-segment elevation myocardial infarction – A substudy from the prospective randomized MOVEMENT trial by Holm, Manne, Tornvall, Per, Beck, Olof, Fux, Thomas, van der Linden, Jan

    Published in Thrombosis update (01-12-2021)
    “…Morphine delays ticagrelor effect in ST-segment elevation myocardial infarction (STEMI) patients, likely due to impaired gastrointestinal motility. The aim was…”
    Get full text
    Journal Article
  2. 2

    The MOVEMENT Trial by Holm, Manne, Tornvall, Per, Henareh, Loghman, Jensen, Ulf, Golster, Nanna, Alström, Patrik, Santos-Pardo, Irene, Witt, Nils, Fedchenko, Nikolai, Venetsanos, Dimitrios, Beck, Olof, van der Linden, Jan

    Published in Journal of the American Heart Association (22-01-2019)
    “…Background Morphine administration is a strong predictor of delayed onset of action of orally administered ticagrelor in patients with ST-segment-elevation…”
    Get full text
    Journal Article
  3. 3

    Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose by Holm, Manne, Tornvall, Per, Westerberg, Julia, Rihan Hye, Shaym, van der Linden, Jan

    Published in Platelets (Edinburgh) (03-10-2017)
    “…The pharmacokinetics after a 180-mg loading dose (LD) of ticagrelor has not been thoroughly investigated in NSTEMI patients. We aimed to compare the ticagrelor…”
    Get full text
    Journal Article
  4. 4

    Correlation Between Point-of-Care Platelet Function Testing and Bleeding After Coronary Angiography According to Two Different Definitions for Bleeding by Holm, Manne, MD, Tornvall, Per, MD, PhD, Dalén, Magnus, MD, van der Linden, Jan, MD, PhD

    Published in The American journal of cardiology (01-11-2014)
    “…Platelet function testing could be useful when assessing the risk for bleeding during treatment with antiplatelet drugs. This has been indicated in several…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Negative Impact of ST-Segment Elevation Myocardial Infarction and Morphine Dose on Ticagrelor Uptake and Pharmacodynamics: A Population PK/PD Analysis of Pooled Individual Participant Data by Konecki, Celine, Holm, Manne, Djerada, Zoubir

    Published in Clinical pharmacokinetics (01-06-2023)
    “…Background Ticagrelor is widely used in patients with stable and acute coronary artery disease. Understanding the factors that influence its pharmacokinetics…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality by Fux, Thomas, Holm, Manne, Corbascio, Matthias, Lund, Lars H., van der Linden, Jan

    “…Refractory postcardiotomy cardiogenic shock is associated with a high mortality, and venoarterial extracorporeal membrane oxygenation can offer acute…”
    Get full text
    Journal Article
  10. 10

    Surgical Outcome Risk Tool (SORT) to predict 30-day postoperative mortality in a mixed surgical population in Swedish tertiary hospitals by Semenas, Egidijus, Helleberg, Johan, Bartha, Erzsébet, Kalman, Sigridur, Holm, Manne

    Published in British journal of surgery (12-04-2023)
    “…Abstract Background The Surgical Outcome Risk Tool (SORT) was derived and validated in the UK to improve preoperative prediction of postoperative risk. The aim…”
    Get full text
    Journal Article
  11. 11

    Cardiac Arrest Prior to Venoarterial Extracorporeal Membrane Oxygenation: Risk Factors for Mortality by Fux, Thomas, Holm, Manne, Corbascio, Matthias, van der Linden, Jan

    Published in Critical care medicine (01-07-2019)
    “…OBJECTIVES:Mortality after cardiac arrest remains high despite initiation of venoarterial extracorporeal membrane oxygenation. We aimed to identify…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Assessment of platelet function after discontinuation of ticagrelor by Söderberg, Martin, Holm, Manne, Gupta, Anil

    Published in Acta anaesthesiologica Scandinavica (01-04-2020)
    “…Background Patients presenting with acute coronary syndromes (ACS) are often treated by percutaneous coronary intervention (PCI) with insertion of coronary…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Calculation Algorithm Reduces Protamine Doses Without Increasing Blood Loss or the Transfusion Rate in Cardiac Surgery: Results of a Randomized Controlled Trial by Kjellberg, Gunilla, Holm, Manne, Fux, Thomas, Lindvall, Gabriella, van der Linden, Jan

    “…The aim of the study was to investigate whether the HeProCalc algorithm affects heparin and protamine dosage, postoperative blood loss, and transfusion rate…”
    Get full text
    Journal Article
  20. 20

    VA‐ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre‐Implant Outcome Predictors by Fux, Thomas, Holm, Manne, Corbascio, Matthias, Lund, Lars H., van der Linden, Jan

    Published in Artificial organs (01-02-2019)
    “…Refractory cardiogenic shock (RCS) is associated with a high mortality. Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used as…”
    Get full text
    Journal Article